Abstract Embargo & Release Information Policy

Below are the policies of the SITC abstract submission process. By submitting an abstract, you are agreeing to abide by these policies.

Abstract Dates Abstract FAQs Abstract Reference Guide

Abstract Titles and Authors

Titles and authors for Regular, Young Investigator Award (YIA) and Immune Engineering Abstracts will be available on Oct. 4, 2024 at 9 a.m. EDT on the SITC Annual Meeting website. Titles and authors for Late-Breaking Abstracts - Clinical Only (LBAs) will be available on Oct. 30, 2024 at 9 a.m. EDT on the SITC Annual Meeting website. Once abstract titles are listed on the website, press releases can be issued with the titles and logistical information. Any planned press releases and media alerts must have been reviewed and approved in advance by SITC Communications staff, additional information on press release is below.

Abstract Embargo Information

Abstract Content Embargo

Full abstract content for Regular, Young Investigator Award (YIA), Immune Engineering Abstracts and Late-Breaking Abstract - Clinical Only (LBA) content will be embargoed until Nov. 5, 2024 at 8 a.m. CST/9 a.m. EST. This includes content within the original abstract submitted, additional data that was available on a poster of the abstract and/or any updated and/or any new data that will be available in oral presentations at the 39^th Annual Meeting and/or the Immune Engineering Workshop.

Poster Presentation Data Embargo

(Posters only): Any additional data that will be available on a poster that is beyond what was submitted in the abstract is embargoed until Nov. 7, 2024 at 9 a.m. CST. This embargo applies to poster-only presentations at the 39^th Annual Meeting and/or the Immune Engineering Workshop.

Oral Presentation Data Embargo

Any updated and/or new data that will be available in an oral presentation is embargoed until the date and time of the presentation. If the oral presenter is also creating a poster which includes updated and/or new data, the poster shares the same Oral Presentation Embargo date, not the poster embargo date specified above. This embargo applies to oral abstract presentations.

Press Release Policy

Any planned press releases and media alerts must have been reviewed and approved in advance by SITC Communications staff. Please provide a minimum for two business days for review. Drafts should be emailed to communications@sitcancer.org.

For press releases about abstracts aimed at being released:

Before 8 a.m. CST/9 a.m. EST on Nov. 5, 2024: Press releases should be issued with only logistical information (abstract title, author, poster number, and presentation date and time) about an abstract/poster/oral presentation

After 8 a.m. CST/9 a.m. EST on Nov. 5, 2024: Press releases should be issued with information about the content within the original abstract submitted, additional data that will be available on a poster of the abstract and/or any updated and/or new data that will be available in oral presentation at SITC’s Annual Meeting

Withdrawal & Editing Policy

Deadlines for withdrawals or changes:

The deadline for Regular, Young Investigator Award, and Immune Engineering Abstract withdrawals, including presenter changes, is Aug. 9, 2024.

The deadline for LBA withdrawals, including presenter changes, is Sept. 30, 2024.

Withdrawal requests must be submitted to education@sitcancer.org.

Requests for changes after the deadlines:

All requests after the deadlines stated above must be emailed to SITC at education@sitcancer.org.

Please note that not all requests may be accommodated.

For requests to change the author list, at minimum written approval from the first author, last author and submitting author is required.

These deadlines are set in place because the abstract information is pulled for publication immediately following these dates and cannot be edited after that. If you would like to withdraw or make a change to your abstract between the submission deadline and this date, you must submit your request in writing to education@sitcancer.org. Upon receipt of your request we will make the change, if possible, and send a confirmation once the withdrawal or change has been completed.

Copyright Policy

Parameters for requesting permission to use abstracts and articles published in JITC are detailed in BMJ’s copyright policy. For detailed information on how to cite, reference, give attribution to, use, reuse, etc. regarding an article or an abstract published in JITC, please consult the publisher, BMJ. You must adhere to the rules in accordance with the type of license granted to BMJ.

SITC Privacy Policy

Please see the SITC Privacy Policy regarding providing your information on SITC platforms and our service providers, including the Abstract Management System provided by The Conference Exchange.

Call for Papers by Publisher

BMJ, the publisher of the Journal for ImmunoTherapy of Cancer (JITC), reserves the right to email corresponding authors of abstracts or Late-breaking Abstracts once they are published to notify them of online publication and to invite them to submit articles to JITC.

Encore Presentation Policy

Any abstract that has been previously accepted and/or published (by any meeting or publisher) must contain substantial new data in order to be considered. Contact education@sitcancer.org with any questions pertaining to substantial new data.

License to Publish

Authors grant an exclusive license on a worldwide basis to BMJ and SITC in accordance with the standard license. It is the responsibility of the nominated coordinator to ensure that the corresponding/lead author of each abstract is aware that by submitting their work for publication they are agreeing to the terms and conditions of BMJ’s standard license to publish for abstracts.

SITC Meeting Code of Conduct

Please see the SITC Meeting Code of Conduct regarding policies for program participants and attendees.

Policies